M&A Deal Summary

Diffusion Pharmaceutical Acquires RestorGenex

On January 8, 2016, Diffusion Pharmaceutical acquired life science company RestorGenex

Acquisition Highlights
  • This is Diffusion Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is Diffusion Pharmaceutical’s 1st transaction in the United States.
  • This is Diffusion Pharmaceutical’s 1st transaction in Illinois.

M&A Deal Summary
Date 2016-01-08
Target RestorGenex
Sector Life Science
Buyer(s) Diffusion Pharmaceutical
Deal Type Merger
Advisor(s) Raymond James - Investment Banking (Financial)
Fox Rothschild (Legal)

Target

RestorGenex

Buffalo Grove, Illinois, United States
RestorGenex Corp. is a biopharmaceutical company with an initial focus on dermatology, ocular diseases and women's health. RestorGenex is based in Buffalo Grove, Illinois.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Diffusion Pharmaceutical

Charlottesville, Virginia, United States
Category Company
Founded 2001
Sector Life Science
Employees12
DESCRIPTION

Diffusion Pharmaceutical is a biotechnology company develops new treatments to improve the body’s ability to bring oxygen to the areas where it is needed most, offering new hope for the treatment of life-threatening medical conditions. Diffusion Pharmaceutical was founded in 2001 and is based in Charlottesville, Virginia.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal